BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15213286)

  • 21. Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
    Gandolfini I; Crespo E; Baweja M; Jarque M; Donadei C; Luque S; Montero N; Allesina A; Perin L; Maggiore U; Cravedi P; Bestard O
    PLoS One; 2018; 13(7):e0200696. PubMed ID: 30059561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.
    Heeger PS; Greenspan NS; Kuhlenschmidt S; Dejelo C; Hricik DE; Schulak JA; Tary-Lehmann M
    J Immunol; 1999 Aug; 163(4):2267-75. PubMed ID: 10438971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
    Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
    Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
    Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A significant role for anti-human leukocyte antigen antibodies and antibody-mediated rejection in the biopsy-for-cause population.
    Banasik M; Kościelska-Kasprzak K; Myszka M; Bartoszek D; Zabińska M; Boratyńska M; Kamińska D; Mazanowska O; Zmonarski S; Krajewska M; Hałoń A; Dawiskiba T; Nowakowska B; Klinger M
    Transplant Proc; 2014 Oct; 46(8):2613-7. PubMed ID: 25380878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool.
    Gebauer BS; Hricik DE; Atallah A; Bryan K; Riley J; Tary-Lehmann M; Greenspan NS; Dejelo C; Boehm BO; Hering BJ; Heeger PS
    Am J Transplant; 2002 Oct; 2(9):857-66. PubMed ID: 12392292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric evaluation of pregnancy-induced anti-donor immunization.
    Ayna TK; Ciftci HS; Tozkir H; Sagiroglu T; Isitmangil G; Gurtekin B; Gurtekin M
    Transplant Proc; 2012; 44(6):1656-9. PubMed ID: 22841238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
    Cardarelli F; Pascual M; Tolkoff-Rubin N; Delmonico FL; Wong W; Schoenfeld DA; Zhang H; Cosimi AB; Saidman SL
    Transpl Int; 2005 May; 18(5):532-40. PubMed ID: 15819801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-lymphocytes support and regulate indirect T-cell alloreactivity in individual patients with chronic antibody-mediated rejection.
    Shiu KY; McLaughlin L; Rebollo-Mesa I; Zhao J; Semik V; Cook HT; Roufosse C; Brookes P; Bowers RW; Galliford J; Taube D; Lechler RI; Hernandez-Fuentes MP; Dorling A
    Kidney Int; 2015 Sep; 88(3):560-8. PubMed ID: 25830760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral Immune Response and Allograft Function in Kidney Transplantation.
    Filippone EJ; Farber JL
    Am J Kidney Dis; 2015 Aug; 66(2):337-47. PubMed ID: 25987262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
    Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HA-1 mismatch has significant effect in chronic allograft nephropathy in clinical renal transplantation.
    Krishnan NS; Higgins RM; Lam FT; Kashi H; Jobson S; Ramaiyan K; Rahman M; Morris A
    Transplant Proc; 2007 Jun; 39(5):1439-45. PubMed ID: 17580157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretransplant donor-specific interferon-gamma ELISPOT assay predicts acute rejection episodes in renal transplant recipients.
    Kim SH; Oh EJ; Kim MJ; Park YJ; Han K; Yang HJ; Kim JY; Choi BS; Yang CW; Kim YS; Bang BK
    Transplant Proc; 2007 Dec; 39(10):3057-60. PubMed ID: 18089321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme-linked immunosorbent assay spot detection of interferon-gamma and interleukin 5-producing cells as a predictive marker for renal allograft failure.
    Tary-Lehmann M; Hricik DE; Justice AC; Potter NS; Heeger PS
    Transplantation; 1998 Jul; 66(2):219-24. PubMed ID: 9701268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
    Liu Z; Colovai AI; Tugulea S; Reed EF; Fisher PE; Mancini D; Rose EA; Cortesini R; Michler RE; Suciu-Foca N
    J Clin Invest; 1996 Sep; 98(5):1150-7. PubMed ID: 8787678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular rejection post heart transplantation is associated with positive flow cytometric cross-matching.
    McCarthy JF; Cook DJ; Massad MG; Sano Y; O'Malley KJ; Ratliff NR; Stewart RW; Smedira NG; Starling RC; Young JB; McCarthy PM
    Eur J Cardiothorac Surg; 1998 Aug; 14(2):197-200. PubMed ID: 9755007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretransplantation cellular alloreactivity is predictive of acute graft rejection and 1-year graft function in kidney transplant recipients.
    Koscielska-Kasprzak K; Drulis-Fajdasz D; Kaminska D; Mazanowska O; Krajewska M; Gdowska W; Bieniecki W; Chudoba P; Polak W; Janczak D; Patrzalek D; Klinger M
    Transplant Proc; 2009 Oct; 41(8):3006-8. PubMed ID: 19857662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.